Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 428-434

  Raasch, Walter ^a   Bartels, Torsten ^a   Gieselberg, Annabella ^a   Dendorfer, Andreas ^a   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINE OXIDASE (FLAVIN CONTAINING); ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN HEXETIL; CAPTOPRIL; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MIBEFRADIL; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; HEART PROTECTION; HYPERTENSION; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; BRAIN CHEMISTRY; CATECHOLAMINES; HEART; HEMODYNAMIC PROCESSES; KINETICS; LIVER; MALE; MITOCHONDRIA; MITOCHONDRIA, LIVER; MONOAMINE OXIDASE; MYOCARDIUM; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0036156524     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.428     Document Type: Article

References (30)

1. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery
2. Inhibition of angiotansin II-induced facilitation of sympathetic neurotransmission in the pithed rat: A comparison between losartan, irbesartan, telmisartan, and captopril
3. Evidence for reduction of norepinephrine uptake sites in the failing human heart
4. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors
5. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase
6. Interactions between the renin-angiotensin system (RAS) and the sympathetic system
7. Synthesis of kininogen and degradation of bradykinin by PC12 cells
8. Biosynthesis of catecholamines and sympathetic outflow in spontaneously hypertensive rats (SHR) after chronic treatment with CE blocking agents
9. Tissue distribution of captopril, reducible captopril conjugates and S-methylcaptopril in the rat
10. The nature of the substrate-selective interaction between rat liver mitochondrial monoamine oxidase and oxygen
11. Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation
12. Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats
13. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure
14. Disposition of the new angiotensin II receptor antagonist candesartan cilexetil in rats and dogs
15. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats
16. Modulation of noradrenaline release in the pithed rabbit: A role for angiotensin II
17. Inhibition of monoamine oxidase by viloxazine in rats
18. Enalapril decreases plasma noradrenaline levels during the cold pressor test in human hypertensives
19. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
20. ACE inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats (SHR)
21. The lipophilic properties of angiotensin I-converting enzyme inhibitors do not influence their diffusion through cultured endothelium
22. Modulation of MAO activity by imidazoline and guanidine derivatives
23. A second redox group in monoamine oxidase: Its role in catalysis and inhibition
24. Myocardial catecholainine concentrations in dilated cardiomyopathy and heart failure of different origins
25. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models
26. Monoamine oxidase contains a redox-active disulfide
27. The effects of peptide and nonpeptide angiotensin II-receptor ligands on the activity of brain monoamine oxidase in water-repleted rats
28. Norepinephrine metabolism in neuronal cultures is increased by angiotensin II
29. Localization of I2-imidazoline binding sites on monoamine oxidases
30. Differential effects of angiotensin II and eledoisin on monoamine oxidase A and B activities in rat brain